SEC 13F Intelligence

Deerfield Management Company, L.P. / LRMR

Deerfield Management Company, L.P.’s Larimar Therapeutics Inc Position

Does Deerfield Management Company, L.P. own Larimar Therapeutics Inc (LRMR)? Yes — 35.61M shares worth $160M (+1.89% of its 13F portfolio) as of Q1 2026, up from 30.61M shares the prior filed quarter.

Position Value
$160M
Q1 2026
Shares
35.61M
% of Portfolio
+1.89%
Quarters Held
24
currently held

Position History LRMR

Reported value by quarter
Q2 ’20: $66MQ2 ’20Q3 ’20: $78MQ4 ’20: $110MQ1 ’21: $75MQ1 ’21Q2 ’21: $57MQ3 ’21: $67MQ4 ’21: $63MQ4 ’21Q1 ’22: $24MQ2 ’22: $11MQ3 ’22: $54MQ3 ’22Q4 ’22: $70MQ1 ’23: $77MQ2 ’23: $53MQ2 ’23Q3 ’23: $67MQ4 ’23: $77MQ1 ’24: $161MQ1 ’24Q2 ’24: $154MQ3 ’24: $139MQ4 ’24: $82MQ4 ’24Q1 ’25: $46MQ2 ’25: $61MQ3 ’25: $99MQ3 ’25Q4 ’25: $117MQ1 ’26: $160Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202635.61M$160M+1.89%
Q4 202530.61M$117M+1.49%
Q3 202530.61M$99M+1.51%
Q2 202521.23M$61M+1.11%
Q1 202521.23M$46M+0.90%
Q4 202421.23M$82M+1.56%
Q3 202421.23M$139M+2.08%
Q2 202421.23M$154M+2.56%
Q1 202421.23M$161M+2.80%
Q4 202316.94M$77M+1.42%
Q3 202316.94M$67M+1.47%
Q2 202316.94M$53M+1.13%
Q1 202316.94M$77M+1.71%
Q4 202216.94M$70M+1.45%
Q3 202216.94M$54M+1.08%
Q2 20225.83M$11M+0.24%
Q1 20225.83M$24M+0.53%
Q4 20215.83M$63M+1.32%
Q3 20215.83M$67M+1.31%
Q2 20215.83M$57M+1.02%
Q1 20215.14M$75M+1.58%
Q4 20205.14M$110M+2.18%
Q3 20205.14M$78M+1.90%
Q2 20205.14M$66M+1.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deerfield Management Company, L.P.’s full portfolio or all institutional holders of LRMR.